Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAUL A KOVACH

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1194733279
CMS profile
596336
Location
GROVE CITY, OH

General Payments · PY2018–2024

$2,685.91

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,287.38

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $694.21 2
Food and Beverage $555.83 4
Education $37.34 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Retrophin, Inc. $1,112.10 10
CALLIDITAS THERAPEUTICS US INC. $113.96 1
AKEBIA THERAPEUTICS INC $44.26 2
NOVARTIS PHARMACEUTICALS CORPORATION $17.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $14.50 1
PY2019 $244.54 4
PY2020 $34.96 2
PY2021 $321.38 6
PY2022 $501.69 10
PY2023 $281.46 6
PY2024 $1,287.38 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $19.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 1145828684 CMS
AKEBIA THERAPEUTICS INC $24.61 08/28/2024 Education Undisputed 01/23/2026 1145832949 CMS
CALLIDITAS THERAPEUTICS US INC. $113.96 05/07/2024 Food and Beverage Undisputed 01/23/2026 1141514585 CMS
Novartis Pharmaceuticals Corporation $17.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 1087144188 CMS
Travere Therapeutics, Inc. $3.08 05/02/2024 Education Undisputed 01/23/2026 1149888181 CMS
Travere Therapeutics, Inc. $2.38 05/06/2024 Education Undisputed 01/23/2026 1149888177 CMS
Travere Therapeutics, Inc. $0.37 09/16/2024 Education Undisputed 01/23/2026 1149888165 CMS
Travere Therapeutics, Inc. $3.08 09/16/2024 Education Undisputed 01/23/2026 1149888186 CMS
Travere Therapeutics, Inc. $0.37 09/17/2024 Education Undisputed 01/23/2026 1149888169 CMS
Travere Therapeutics, Inc. $3.08 09/17/2024 Education Undisputed 01/23/2026 1149888189 CMS
Travere Therapeutics, Inc. $238.26 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149888193 CMS
Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 1149888197 CMS
Travere Therapeutics, Inc. $455.95 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149888201 CMS
Travere Therapeutics, Inc. $0.37 10/07/2024 Education Undisputed 01/23/2026 1149888173 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.